ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 78 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $16,000 | -84.3% | 12,777 | -84.8% | 0.00% | -100.0% |
Q2 2020 | $102,000 | +21.4% | 84,329 | +113.0% | 0.00% | – |
Q4 2019 | $84,000 | +47.4% | 39,588 | +140.9% | 0.00% | -100.0% |
Q1 2019 | $57,000 | +72.7% | 16,433 | +1.4% | 0.00% | 0.0% |
Q4 2017 | $33,000 | -81.8% | 16,200 | -58.9% | 0.00% | -66.7% |
Q3 2017 | $181,000 | +39.2% | 39,375 | +16.5% | 0.00% | -78.6% |
Q4 2015 | $130,000 | – | 33,800 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 3,731,342 | $8,022,000 | 0.40% |
WealthTrust Axiom LLC | 210,000 | $451,000 | 0.17% |
Palo Alto Investors LP | 1,032,715 | $2,220,000 | 0.10% |
ELEMENT CAPITAL MANAGEMENT LLC | 144,536 | $311,000 | 0.06% |
SHEPHERD KAPLAN KROCHUK, LLC | 49,761 | $107,000 | 0.06% |
Joel Isaacson & Co., LLC | 70,660 | $152,000 | 0.03% |
LMR Partners LLP | 148,309 | $319,000 | 0.02% |
LINCOLN CAPITAL CORP | 10,000 | $22,000 | 0.02% |
Malaga Cove Capital, LLC | 13,150 | $28,000 | 0.02% |
Cornerstone Capital, Inc. | 30,000 | $65,000 | 0.01% |